Literature DB >> 27689239

Treatment options for hypertension in pregnancy and puerperium.

Farah H Amro1, Hind N Moussa2, Olaide A Ashimi2, Baha M Sibai2.   

Abstract

INTRODUCTION: Hypertensive disorders have become increasingly prevalent and complicate an increasing number of pregnancies. Therefore it is essential that the medications used to treat these disorders be well understood. Furthermore the management is complicated by special consideration needed for the physiologic changes of pregnancy as well as the consideration for possible adverse fetal effects. Areas covered: We performed a review of the scientific literature of medications used to treat hypertensive disorders in pregnancy. We reviewed the guidelines used by different societies all over the world. We also discussed the pharmacodynamics, pharmacokinetics and possible adverse effects relating to the antihypertensive medications. Finally, we discussed the long-term maternal implications of these diseases. Expert opinion: Overall, we encourage a step-wise approach to treating hypertensive disorders of pregnancy. While making sure to max out the use of one medications prior to shifting to another. Also, it is imperative not to be aggressive with treatment due to risk of compromising utero-placental blood flow. There is research currently involving biomarkers, nano-medicine and the placenta project with hopes of developing new targeted medications with a good fetal safety profile.

Entities:  

Keywords:  Antihypertensives; chronic hypertension; drugs; gestational hypertension; labetalol; methyldopa; nifedipine; preeclampsia; preeclampsia with severe features; pregnancy; teratogenesis

Mesh:

Substances:

Year:  2016        PMID: 27689239     DOI: 10.1080/14740338.2016.1237500

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  4 in total

1.  Hypertensive disorders in pregnancy.

Authors:  Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2017-06

2.  A double-blinded, randomized, placebo-controlled trial assessing the effects of nifedipine on embryo transfer: Study protocol.

Authors:  Kelvin Kl Ng; Genia Rozen; Tanya Stewart; Franca Agresta; Alex Polyakov
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

3.  Does nifedipine improve outcomes of embryo transfer?: Interim analysis of a randomized, double blinded, placebo-controlled trial.

Authors:  Kelvin Kwok Lap Ng; Genia Rozen; Tanya Stewart; Franca Agresta; Alex Polyakov
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

4.  Pre-eclampsia with severe features: management of antihypertensive therapy in the postpartum period.

Authors:  Nnabuike Chibuoke Ngene; Jagidesa Moodley
Journal:  Pan Afr Med J       Date:  2020-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.